John C Aplin - Net Worth and Insider Trading
John C Aplin Net Worth
The estimated net worth of John C Aplin is at least $505,301 dollars as of 2025-07-08. John C Aplin is the Director of Endocyte Inc and owns about 21,063 shares of Endocyte Inc (ECYT) stock worth over $505,301. Details can be seen in John C Aplin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John C Aplin has not made any transactions after 2011-12-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of John C Aplin
John C Aplin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John C Aplin owns 2 companies in total, including Endocyte Inc (ECYT) , and Stereotaxis Inc (STXS) .
Click here to see the complete history of John C Aplin’s form 4 insider trades.
Insider Ownership Summary of John C Aplin
Ticker | Company | Transaction Date | Type of Owner |
---|---|---|---|
ECYT | Endocyte Inc | 2018-12-21 | director |
STXS | Stereotaxis Inc | 2004-08-11 | director |
John C Aplin Latest Holdings Summary
John C Aplin currently owns a total of 1 stock. John C Aplin owns 21,063 shares of Endocyte Inc (ECYT) as of December 16, 2011, with a value of $505,301.
Latest Holdings of John C Aplin
Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ECYT | Endocyte Inc | 2011-12-16 | 21,063 | 23.99 | 505,301 |
Holding Weightings of John C Aplin
John C Aplin Form 4 Trading Tracker
According to the SEC Form 4 filings, John C Aplin has made a total of 0 transactions in Endocyte Inc (ECYT) over the past 5 years. The most-recent trade in Endocyte Inc is the acquisition of 20,000 shares on December 16, 2011, which cost John C Aplin around $65,400.
Insider Trading History of John C Aplin
- 1
John C Aplin Trading Performance
GuruFocus tracks the stock performance after each of John C Aplin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John C Aplin is 70.26%. GuruFocus also compares John C Aplin's trading performance to market benchmark return within the same time period. The performance of stocks bought by John C Aplin within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John C Aplin's insider trading performs compared to the benchmark.
Performance of John C Aplin
John C Aplin Ownership Network
Ownership Network List of John C Aplin
Ownership Network Relation of John C Aplin

John C Aplin Owned Company Details
What does Endocyte Inc do?
Who are the key executives at Endocyte Inc?
John C Aplin is the director of Endocyte Inc. Other key executives at Endocyte Inc include VP Finance & Chief Acctg Off Beth Taylor , General Counsel David R. Mcavoy , and Chief Medical Officer Alison A. Armour .
Endocyte Inc (ECYT) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Endocyte Inc (ECYT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Endocyte Inc (ECYT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Endocyte Inc (ECYT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Endocyte Inc Insider Transactions
John C Aplin Mailing Address
Above is the net worth, insider trading, and ownership report for John C Aplin. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, John C Aplin's mailing address is: Indianapolis In 46282.